LOGIN JOIN SHARECAFE SIGN UP FOR OUR NEWSLETTER ADVERTISE
share cafe logo  
 
SEARCH RESULT

CSL LIMITED ( CSL )

Discuss CSL In The ShareScene Community


CLICK HERE TO TALK WITH OTHER INVESTORS ABOUT CSL +

CSL Commentary, Multimedia & ASX Announcements


CSL Provides Trifecta Of Good News2/15/2018 8:06:55 AM
CSL Climbs To New High On Bullish Broker Upgrades 1/30/2018 7:58:04 AM
CSL Bets Big On Heart Attack Treatment12/6/2017 8:07:28 AM
CSL - UBS rates the stock as Buy10/10/2017 11:46:36 AM
Reform Risk Overhangs Life Healthcare10/9/2017 1:04:29 PM
Great Result Out Of CSL, So Is It Now A buy?8/30/2017 10:55:26 AM
CSL In US Expansion8/29/2017 8:22:09 AM
CSL - Morgans rates the stock as Add8/17/2017 9:59:06 AM
High Expectations Hurt CSL8/17/2017 8:24:25 AM
CSL - Morgan Stanley rates the stock as Equal-weight8/8/2017 10:02:17 AM
CSL - UBS rates the stock as Buy7/12/2017 11:59:08 AM
CSL - Morgan Stanley rates as Equal-weight6/14/2017 10:19:34 AM
CSL Soars On China Expansion Plans6/14/2017 7:54:03 AM
CSL - UBS rates the stock as Neutral5/4/2017 11:15:15 AM
CSL - Credit Suisse rates the stock as Outperform2/16/2017 10:17:06 AM
CSL Lifts Profit By 12%2/16/2017 7:50:54 AM
CSL - Morgans rates the stock as Add1/20/2017 10:58:59 AM
CSL Lifts Profit Forecast1/20/2017 8:28:21 AM
Bear Put Spread On CSL Limited 1/19/2017 10:07:59 AM
CSL Confirms Buyback10/13/2016 8:11:58 AM
CSL - Morgans rates the stock as Add9/21/2016 11:13:18 AM
CSL - Macquarie rates the stock as Outperform8/18/2016 10:38:30 AM
Flu Vaccine Business Hits CSL8/18/2016 8:00:55 AM
CSL - Morgan Stanley rates as Underweight8/12/2016 10:36:11 AM
Could CSL Be Worth More Than $150 A Share?6/3/2016 3:21:36 PM
CSL - Macquarie rates the stock as Outperform4/11/2016 11:04:37 AM
CSL - Credit Suisse rates the stock as Neutral3/15/2016 10:27:13 AM
US Greenlights CSL Treatment3/8/2016 7:41:00 AM
CSL Profit Up 3.8%2/17/2016 8:16:53 AM
CSL - Credit Suisse rates the stock as Outperform12/11/2015 12:38:58 PM
CSL - Credit Suisse rates the stock as Outperform11/4/2015 12:50:17 PM
Back To Back Buybacks At CSL10/16/2015 7:24:05 AM
Time to Sell CSL?8/25/2015 7:57:37 AM
One Offs Cloud CSL Result8/13/2015 7:59:53 AM
CSL Hits $100...Again8/4/2015 5:29:55 PM
CSL - Deutsche Bank rates the stock as Buy8/3/2015 2:05:34 PM
US FDA To Review CSL Treatment7/29/2015 8:10:17 AM
Should You Buy CSL?6/26/2015 12:36:24 PM
CSL - Morgans rates the stock as Add6/19/2015 10:42:47 AM
CSL - Credit Suisse rates the stock as Outperform6/9/2015 12:12:11 PM
CSL - UBS rates the stock as Buy3/9/2015 12:29:55 PM
CSL Shares Hit By Earnings Slowdown 2/12/2015 8:52:21 AM
CSL - Citi rates the stock as Sell11/6/2014 12:33:14 PM
A Bargain Buy10/29/2014 12:39:47 PM
CSL Continues To Spend Big10/28/2014 7:53:03 AM
New CSL Buyback To Reward Shareholders 10/16/2014 8:22:53 AM
CSL Plans For Expansion10/13/2014 3:18:54 PM
CSL - CIMB Securities rates the stock as Hold9/17/2014 12:30:12 PM
CSL - Deutsche Bank rates the stock as Buy8/15/2014 12:22:55 PM
CSL - UBS rates the stock as Buy8/14/2014 2:33:35 PM

There Is No Multimedia Available For This Company.

Company Secretary Appointment/Resignation 12/21/2017 9:31:00 AM
Change to Company Details 4/21/2017 11:30:00 AM
Daily share buy-back notice - Appendix 3E 4/21/2017 8:37:00 AM
Daily share buy-back notice - Appendix 3E 4/20/2017 8:33:00 AM
Daily share buy-back notice - Appendix 3E 4/18/2017 8:45:00 AM
CSL Half Year Report 2016/17 4/13/2017 11:41:00 AM
Daily share buy-back notice - Appendix 3E 4/13/2017 8:31:00 AM
CSL Response to Patent Complaint 4/12/2017 9:49:00 AM
Daily share buy-back notice - Appendix 3E 4/10/2017 8:36:00 AM
Daily share buy-back notice - Appendix 3E 4/7/2017 8:25:00 AM
Daily share buy-back notice - Appendix 3E 4/6/2017 7:53:00 AM
Daily share buy-back notice - Appendix 3E 4/5/2017 8:50:00 AM
Daily share buy-back notice - Appendix 3E 4/4/2017 8:26:00 AM
Daily share buy-back notice - Appendix 3E 4/3/2017 8:24:00 AM
Daily share buy-back notice - Appendix 3E 3/31/2017 11:33:00 AM
Daily share buy-back notice - Appendix 3E 3/30/2017 8:52:00 AM
Change to Company Details 3/29/2017 11:57:00 AM
Daily share buy-back notice - Appendix 3E 3/29/2017 8:27:00 AM
Appendix 3B 3/28/2017 9:56:00 AM
Daily share buy-back notice - Appendix 3E 3/28/2017 8:29:00 AM
Daily share buy-back notice - Appendix 3E 3/27/2017 9:04:00 AM
Daily share buy-back notice - Appendix 3E 3/24/2017 9:07:00 AM
Daily share buy-back notice - Appendix 3E 3/23/2017 10:16:00 AM
Daily share buy-back notice - Appendix 3E 3/23/2017 8:28:00 AM
Daily share buy-back notice - Appendix 3E 3/22/2017 8:44:00 AM
Daily share buy-back notice - Appendix 3E 3/21/2017 8:27:00 AM
Daily share buy-back notice - Appendix 3E 3/20/2017 8:47:00 AM
Daily share buy-back notice - Appendix 3E 3/17/2017 8:51:00 AM
Daily share buy-back notice - Appendix 3E 3/16/2017 8:57:00 AM
Daily share buy-back notice - Appendix 3E 3/15/2017 8:24:00 AM
Daily share buy-back notice - Appendix 3E 3/14/2017 8:29:00 AM
Daily share buy-back notice - Appendix 3E 3/14/2017 8:28:00 AM
Daily share buy-back notice - Appendix 3E 3/10/2017 8:26:00 AM
Change of Company Details 3/10/2017 8:22:00 AM
Daily share buy-back notice - Appendix 3E 3/9/2017 8:27:00 AM
Daily share buy-back notice - Appendix 3E 3/8/2017 8:28:00 AM
Appendix 3B 3/7/2017 2:22:00 PM
Daily share buy-back notice - Appendix 3E 3/7/2017 8:27:00 AM
Becoming a substantial holder 3/7/2017 8:27:00 AM
Daily share buy-back notice - Appendix 3E 3/6/2017 8:28:00 AM
Ceasing to be a substantial holder 3/6/2017 8:26:00 AM
Becoming a substantial holder 3/3/2017 9:33:00 AM
Daily share buy-back notice - Appendix 3E 3/3/2017 8:27:00 AM
Ceasing to be a substantial holder 3/2/2017 8:26:00 AM
Daily share buy-back notice - Appendix 3E 3/2/2017 8:25:00 AM

 

RECENTLY ADDED TO SHARECAFE


 › Wednesday At The Close
 › The New Criterion: Exploring Mining Services
 › Market At Midday On Wednesday
 › International LMIs Outperform
 › Pet Play Greencross Profit Edges Higher
 › Temple & Webster Narrows Loss
 › Turnaround Pending For Village Roadshow?
 › Bapcor Drives Dividend, Profits Higher
 › Overnight: Here We Go Again?
 › A New Silk Road Paved With Opportunities
 › ANZ - Morgan Stanley rates the stock as Equal-weight
 › FXL - UBS rates the stock as Neutral
 › BHP - Macquarie rates the stock as Outperform
 › Oil Search Eyes Eyes PNG Expansion As Profit Triples
More ShareCafe   

GET THE SHARECAFE BREAKFAST BRIEFING


Delivered free to your inbox before the market opens each trading day. Sign up below +

SHARECAFE VIDEO


View More Videos